Citation: Ea. Walker et al., IN-VIVO APPARENT AFFINITY AND EFFICACY ESTIMATES FOR MU-OPIATES IN A RAT TAIL-WITHDRAWAL ASSAY, Psychopharmacology, 136(1), 1998, pp. 15-23
Citation: G. Zernig et Hc. Fibiger, ACUTE AND PROLONGED EFFECTS OF CLOCINNAMOX AND METHOCLOCINNAMOX ON NUCLEUS-ACCUMBENS DOPAMINE OVERFLOW, Psychopharmacology, 135(1), 1998, pp. 17-21
Authors:
BUTELMAN ER
KO MC
SOBCZYKKOJIRO K
MOSBERG HI
VANBEMMEL B
ZERNIG G
WOODS JH
Citation: Er. Butelman et al., KAPPA-OPIOID RECEPTOR-BINDING POPULATIONS IN RHESUS-MONKEY BRAIN - RELATIONSHIP TO AN ASSAY OF THERMAL ANTINOCICEPTION, The Journal of pharmacology and experimental therapeutics, 285(2), 1998, pp. 595-601
Citation: Mt. Taber et al., OPIOID RECEPTOR MODULATION OF FEEDING-EVOKED DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS, Brain research, 785(1), 1998, pp. 24-30
Citation: G. Zernig et al., CLOCINNAMOX INHIBITS THE INTRAVENOUS SELF-ADMINISTRATION OF OPIOID AGONISTS IN RHESUS-MONKEYS - COMPARISON WITH EFFECTS ON OPIOID AGONIST-MEDIATED ANTINOCICEPTION, Psychopharmacology, 129(3), 1997, pp. 233-242
Citation: G. Zernig et al., NICOTINE AND HEROIN AUGMENT COCAINE-INDUCED DOPAMINE OVERFLOW IN NUCLEUS-ACCUMBENS, European journal of pharmacology, 337(1), 1997, pp. 1-10
Citation: G. Zernig et al., CALCULATION OF AGONIST EFFICACY, APPARENT AFFINITY, AND RECEPTOR POPULATION-CHANGES AFTER ADMINISTRATION OF INSURMOUNTABLE ANTAGONISTS - COMPARISON OF DIFFERENT ANALYTICAL APPROACHES, Journal of pharmacological and toxicological methods, 35(4), 1996, pp. 223-237
Citation: G. Zernig et al., MECHANISM OF CLOCINNAMOX BLOCKADE OF OPIOID RECEPTORS - EVIDENCE FROMIN-VITRO AND EX-VIVO BINDING AND BEHAVIORAL ASSAYS, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 23-31
Authors:
ZERNIG G
ISSAEVITCH T
BROADBEAR JH
BURKE TF
LEWIS JW
BRINE GA
WOODS JH
Citation: G. Zernig et al., RECEPTOR RESERVE AND AFFINITY OF MU-OPIOID AGONISTS IN MOUSE ANTINOCICEPTION - CORRELATION WITH RECEPTOR-BINDING, Life sciences, 57(23), 1995, pp. 2113-2125
Citation: Ea. Walker et al., BUPRENORPHINE ANTAGONISM OF MU-OPIOIDS IN THE RHESUS-MONKEY TAIL-WITHDRAWAL PROCEDURE, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1345-1352
Citation: Er. Butelman et al., BUTORPHANOL - CHARACTERIZATION OF AGONIST AND ANTAGONIST EFFECTS IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 845-853
Citation: G. Zernig et al., IN-VIVO DETERMINATION OF MU-OPIOID RECEPTOR RESERVE AND TURNOVER IN RHESUS-MONKEYS AFTER IRREVERSIBLE BLOCKADE WITH CLOCINNAMOX, Regulatory peptides, 1994, pp. 190000059-190000060
Authors:
ZERNIG G
BUTELMAN ER
LEWIS JW
WALKER EA
WOODS JH
Citation: G. Zernig et al., IN-VIVO DETERMINATION OF MU-OPIOID RECEPTOR TURNOVER IN RHESUS-MONKEYS AFTER IRREVERSIBLE BLOCKADE WITH CLOCINNAMOX, The Journal of pharmacology and experimental therapeutics, 269(1), 1994, pp. 57-65
Citation: A. Saria et al., DIFFERENT BEHAVIORAL PROFILES OF THE NONPEPTIDE SUBSTANCE-P (NK-1) ANTAGONISTS CP-96,345 AND RP-67580, Regulatory peptides, 46(1-2), 1993, pp. 346-348
Citation: G. Zernig et N. Reider, ION DEPENDENCE OF THE PARTIALLY PURIFIED MITOCHONDRIAL DIHYDROPYRIDINE CA2+ ANTAGONIST RECEPTOR, Molecular pharmacology, 41(1), 1992, pp. 45-52